运用分子生物学方法进行癌症基因突变检测,不仅可以对肿瘤疾病提供更好的临床诊断,还可对癌症病人提供最佳的治疗方案。过去,由于癌症患者检测基因突变的费用高昂,且操作复杂,限制了该方法在临床上的应用。近期有两项研究在解决基因检测的局限性方面有了重大进展。假定基因突变 The use of molecular biology to detect mutations in cancer genes not only provides better clinical diagnosis of cancer diseases, but also provides cancer patients with the best treatment options. In the past, the cost of detecting genetic mutations in cancer patients was high and its operation was complicated, which limited its clinical application. Two recent studies have shown significant advances in addressing the limitations of genetic testing. It is assumed that the gene is mutated